Recently, Murray et al. suggested that ApoE ε4 is required in TREM2 R47H variant-carriers for AD to develop, although larger cohorts and statistical analyses are needed to support this hypothesis [160]. The gene discussed is APOE; the disease is Alzheimer disease.